D-1145-2023 Class III Terminated
FDA drug recall D-1145-2023 was initiated by Ascend Laboratories, LLC on Jul 18, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability. The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 99,516 sachets.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 13, 2023
- Initiation Date
- Jul 18, 2023
- Termination Date
- Feb 19, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99,516 sachets
Product description
Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Distribution pattern
The recall product was distributed nationwide.
Code information
Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1145-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026